These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10679403)

  • 41. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.
    Gasque P; Thomas A; Fontaine M; Morgan BP
    J Neuroimmunol; 1996 May; 66(1-2):29-40. PubMed ID: 8964911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement regulatory proteins in glomerular diseases.
    Nangaku M
    Kidney Int; 1998 Nov; 54(5):1419-28. PubMed ID: 9844117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
    J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
    Taylor CT; Johnson PM
    Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
    van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
    Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
    [No Abstract]   [Full Text] [Related]  

  • 46. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
    Seya T
    Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
    [No Abstract]   [Full Text] [Related]  

  • 47. [Complement regulatory proteins CR 1, MCP, DAF, and MACIF levels in patients with Behçet's disease].
    Kure T; Kogure M
    Nippon Ganka Gakkai Zasshi; 1996 May; 100(5):376-80. PubMed ID: 8651056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 49. Protection of thyroid cancer cells by complement-regulatory factors.
    Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
    Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
    Varsano S; Frolkis I; Shapiro H; Ophir D
    Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
    Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Complement regulatory membrane factors in experimental animal models].
    Okada N
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):631-3. PubMed ID: 8963768
    [No Abstract]   [Full Text] [Related]  

  • 53. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
    Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
    Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms.
    Atkinson JP; Krych M; Nickells M; Birmingham D; Subramanian VB; Clemenza L; Alvarez J; Liszewski K
    Clin Exp Immunol; 1994 Aug; 97 Suppl 2(Suppl 2):1-3. PubMed ID: 8070139
    [No Abstract]   [Full Text] [Related]  

  • 56. [Complement regulatory factors and immunologic recognition mechanism between species].
    Seya T; Matsunoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
    Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
    Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
    J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormonal regulation of complement components and receptors throughout the menstrual cycle.
    Hasty LA; Lambris JD; Lessey BA; Pruksananonda K; Lyttle CR
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):168-75. PubMed ID: 7507644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.